Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 72072239 | Other Grant/Funding Number | Dairy Farmers of Canada |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of the Dairy vs Plant study is to compare the effects of dairy and plant-based alternative products on blood sugar regulation and nutrient quality in adolescents and older adults. We are inviting healthy, non-diabetic participants aged 14-18 and 60-75, both males and females to participate. The study will take place in the Nutrition Intervention Center located at the Department of Nutritional Sciences, University of Toronto St. George campus. Participants will be asked to come to the Nutrition Intervention Center on 3 separate occasions: once for an in-person screening lasting approximately 30min and 2 times for study visits lasting approximately 2.5 hrs each. The entire study will take a minimum of 2 weeks to complete. You will be asked to fast for 12hrs (overnight) prior to each study visit. You will also be instructed to maintain the same dietary and sleep patterns, refrain from exercise and alcohol consumption the days before the study visits. During these study visits, you will be asked to consume either a dairy or a plant-based alternative product, as well as a pizza meal. You will periodically fill out questionnaires rating your feelings and perceptions and provide blood samples through finger pricks and intravenously through forearm to measure blood sugar, insulin, hormones, and amino acids. You will be compensated for your time and travel expenses.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Dairy | Experimental | Participants will consume 2 servings of a commerically available dairy product. |
|
| Plant-based alternative | Experimental | Participants will consume 2 servings of a commercially available plant-based alternative product. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Dairy | Other | The dairy products that participants will be required to consume include: 1) Trial 1: 2% cow's milk; 2) Trial 2: dairy yogurt; 3) Trial 3: 2% cottage cheese; 4) Trial 4: 2% cow's milk; and 5) Trial 5: isolated whey protein beverage. Participants will only be enrolled in 1 of the 5 trials; as such, they will only consume the 1 dairy product in that trial. |
| Measure | Description | Time Frame |
|---|---|---|
| Blood glucose | Blood glucose will be measured via finger-prick using a glucose meter at 0, 20, 35, 50, 65, 95, 125, and 145 minutes after treatment consumption. | Over 145 minutes after treatment consumption at each session, for a total of 2 weekly sessions. |
| Measure | Description | Time Frame |
|---|---|---|
| Insulin | Insulin will be measured in the plasma through intravenous blood collection at 0, 35, 65, 95, 125, and 145 minutes after treatment consumption. | Over 145 minutes after treatment consumption at each session, for a total of 2 weekly sessions. |
| Glucagon-like Peptide-1 (GLP-1) |
| Measure | Description | Time Frame |
|---|---|---|
| Appetite | Appetite will be assessed through Adaptive Visual Analogue Scales (AVAS) questionnaires completed at 0, 20, 35, 50, 65, 95, 125 and 145 minutes after treatment consumption, and through an ad libitum pizza meal provided at 125 minutes post-treatment consumption, where participants will be instructed to eat until they are comfortably full over 20 minutes. | Over 145 minutes after treatment consumption at each session, for a total of 2 weekly sessions. |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Corrina Zhou, MSc | Contact | 416-946-3802 | corrina.zhou@mail.utoronto.ca | |
| Amira Amr, PhD | Contact | 416-946-3802 | amira.amr@utoronto.ca |
| Name | Affiliation | Role |
|---|---|---|
| G. Harvey Anderson, PhD | University of Toronto | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Nutrition Intervention Center | Recruiting | Toronto | Ontario | M5S 3H2 | Canada |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 39146559 | Background | Da Silva N, Anderson G, Amr A, Vien S, Fabek H. A comparison of the effects of dairy products with their plant-based alternatives on metabolic responses in healthy young Canadian adults: a randomized crossover study. Appl Physiol Nutr Metab. 2025 Jan 1;50:1-17. doi: 10.1139/apnm-2024-0158. |
Not provided
Not provided
IPD will not be shared, as all data will be de-identified and pooled during the analysis. Only researchers directly involved in the study will have access to the data.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D050177 | Overweight |
| ID | Term |
|---|---|
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
| D001835 | Body Weight |
Not provided
Not provided
| ID | Term |
|---|---|
| D008892 | Milk |
| D015014 | Yogurt |
| D002611 | Cheese |
| D000067796 | Whey |
| D000095866 | Meat Substitutes |
| D041942 | Soy Milk |
| D045730 | Soy Foods |
| ID | Term |
|---|---|
| D001628 | Beverages |
| D000066888 | Diet, Food, and Nutrition |
| D010829 | Physiological Phenomena |
| D003611 | Dairy Products |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
|
| Plant-based alternative | Other | The plant-based products that participants will be required to consume include: 1) Trial 1: soy beverage; 2) Trial 2: plant-based yogurt; 3) Trial 3: tofu; 4) Trial 4: 2% simulated milk; and 5) Trial 5: isolated soy protein beverage. Participants will only be enrolled in 1 of the 5 trials; as such, they will only consume the 1 plant-based alternative product in that trial. |
|
|
GLP-1 will be measured in the plasma through intravenous blood collection at 0, 35, 65, 95, 125, and 145 minutes after treatment consumption. |
| Over 145 minutes after treatment consumption at each session, for a total of 2 weekly sessions. |
| Glucagon-like Peptide-2 (GLP-2) | GLP-2 will be measured in the plasma through intravenous blood collection at 0, 35, 65, 95, 125, and 145 minutes after treatment consumption. | Over 145 minutes after treatment consumption at each session, for a total of 2 weekly sessions. |
| Gastric Inhibitory Polypeptide (GIP) | GIP will be measured in the plasma through intravenous blood collection at 0, 35, 65, 95, 125, and 145 minutes after treatment consumption. | Over 145 minutes after treatment consumption at each session, for a total of 2 weekly sessions. |
| Leptin | Leptin will be measured in the plasma through intravenous blood collection at 0, 35, 65, 95, 125, and 145 minutes after treatment consumption. | Over 145 minutes after treatment consumption at each session, for a total of 2 weekly sessions. |
| Peptide YY (PYY) | PYY will be measured in the plasma through intravenous blood collection at 0, 35, 65, 95, 125, and 145 minutes after treatment consumption. | Over 145 minutes after treatment consumption at each session, for a total of 2 weekly sessions. |
| Cholecystokinin (CCK) | CCK will be measured in the plasma through intravenous blood collection at 0, 35, 65, 95, 125, and 145 minutes after treatment consumption. | Over 145 minutes after treatment consumption at each session, for a total of 2 weekly sessions. |
| Ghrelin | Ghrelin will be measured in the plasma through intravenous blood collection at 0, 35, 65, 95, 125, and 145 minutes after treatment consumption. | Over 145 minutes after treatment consumption at each session, for a total of 2 weekly sessions. |
| Adiponectin | Adiponectin will be measured in the plasma through intravenous blood collection at 0, 35, 65, 95, 125, and 145 minutes after treatment consumption. | Over 145 minutes after treatment consumption at each session, for a total of 2 weekly sessions. |
| Amino Acids | Amino acid concentrations will be measured in the plasma through intravenous blood collection at 0, 35, 65, 95, 125, and 145 minutes after treatment consumption. | Over 145 minutes after treatment consumption at each session, for a total of 2 weekly sessions. |
| D012816 |
| Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D005502 |
| Food |
| D019602 | Food and Beverages |
| D043302 | Cultured Milk Products |
| D000074421 | Fermented Foods |
| D041941 | Milk Substitutes |
| D000067075 | Vegetable Products |
| D014675 | Vegetables |